4.3 Article

Cholesterol in β-cell Dysfunction: The Emerging Connection Between HDL Cholesterol and Type 2 Diabetes

期刊

CURRENT DIABETES REPORTS
卷 10, 期 1, 页码 55-60

出版社

CURRENT MEDICINE GROUP
DOI: 10.1007/s11892-009-0090-x

关键词

Islet; Beta cell; Cholesterol; HDL

资金

  1. Canadian Institutes of Health Research
  2. Michael Smith Foundation for Health Research Senior Scholar

向作者/读者索取更多资源

beta-cell dysfunction is a critical step in the pathogenesis of type 2 diabetes. The mechanisms responsible for beta-cell death and dysfunction remain incompletely understood, but include glucolipotoxicity, the deleterious metabolic milieu created by high plasma concentrations of glucose and lipid species. Recently, an important role has emerged for cholesterol in this process. In this article, we review recent advances in our understanding of the role of ABCA1 and cholesterol metabolism in beta-cell function, with particular attention to insights gained from human studies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Restoration of c-Src/Fyn Proteins Rescues Mitochondrial Dysfunction in Huntington's Disease

Ligia Fao, Patricia Coelho, Luis Duarte, Rita Vilaca, Michael R. Hayden, Sandra I. Mota, Ana Cristina Rego

Summary: This study demonstrates that c-Src/Fyn proteins play an important role in controlling mitochondrial function and redox regulation in Huntington's disease (HD). Restoring c-Src/Fyn levels in HD improves mitochondrial morphology and function, reducing the levels of oxidant species and cell death. These findings suggest that c-Src/Fyn could be a potential therapeutic target for HD.

ANTIOXIDANTS & REDOX SIGNALING (2023)

Article Cell Biology

Nucleoporin POM121 signals TFEB-mediated autophagy via activation of SIGMAR1/sigma-1 receptor chaperone by pridopidine

Shao-Ming Wang, Hsiang-En Wu, Yuko Yasui, Michal Geva, Michael Hayden, Tangui Maurice, Mauro Cozzolino, Tsung-Ping Su

Summary: Autophagy is a crucial cellular process with implications in various diseases. In this study, researchers discovered that the molecular chaperone SIGMAR1 is involved in the transport of TFEB into the nucleus by chaperoning the NP protein POM121, which is responsible for recruiting KPNB1. The disruption of this process in ALS-FTD patients with the C9orf72 subtype leads to impaired autophagy. However, overexpression of SIGMAR1 or POM121, as well as treatment with pridopidine, a SIGMAR1 agonist, can rescue these deficits, suggesting their potential therapeutic use.

AUTOPHAGY (2023)

Article Multidisciplinary Sciences

Autocrine FGF1 signaling promotes glucose uptake in adipocytes

Vera J. M. Nies, Dicky Struik, Sihao Liu, Weilin Liu, Janine K. Kruit, Michael Downes, Tim van Zutphen, Henkjan J. Verkade, Ronald M. Evans, Johan W. Jonker

Summary: This study found that FGF1 can increase glucose uptake in adipocytes by activating GLUT4 protein. Furthermore, prolonged exposure to FGF1 can stimulate adipocyte glucose uptake by transcription of GLUT1 protein.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Biology

Allele-specific quantitation of ATXN3 and HTT transcripts in polyQ disease models

Pawel Joachimiak, Adam Ciesiolka, Emilia Kozlowska, Pawel M. Switonski, Grzegorz Figura, Agata Ciolak, Grazyna Adamek, Magdalena Surdyka, Zaneta Kalinowska-Poska, Maciej Figiel, Nicholas S. S. Caron, Michael R. R. Hayden, Agnieszka Fiszer

Summary: This study used SNP variants to quantitatively determine the allele-specific expression levels in patient-derived cell lines for spinocerebellar ataxia type 3 (SCA3) and Huntington's disease (HD). They found differences in allele expression levels and developed a reliable and quantitative method using SNP-based droplet digital PCR (ddPCR) to analyze low abundant transcripts. This allele-selective approach provides insights into allele-related mechanisms and can improve understanding of polyglutamine diseases.

BMC BIOLOGY (2023)

Article Physiology

Full-length huntingtin is palmitoylated at multiple sites and post-translationally myristoylated following caspase-cleavage

Fanny L. Lemarie, Shaun S. Sanders, Yen Nguyen, Dale D. O. Martin, Michael R. Hayden

Summary: Huntington's disease is a neurodegenerative disorder caused by CAG repeat expansion in the HTT gene. We found that huntingtin protein can be palmitoylated at cysteine 214, and proteolytic cleavage at aspartate 552 leads to myristoylation at glycine 553. Blocking caspase cleavage at aspartate 586 increases myristoylation of huntingtin and promotes the interaction between C-terminal and N-terminal fragments.

FRONTIERS IN PHYSIOLOGY (2023)

Article Neurosciences

Axonal ER Ca2+ Release Selectively Enhances Activity-Independent Glutamate Release in a Huntington Disease Model

James P. Mackay, Amy I. Smith-Dijak, Ellen T. Koch, Peng Zhang, Evan Fung, Wissam B. Nassrallah, Caodu Buren, Mandi Schmidt, Michael R. Hayden, Lynn A. Raymond

Summary: Miniature neurotransmission is increased in the Huntington disease (HD) model, associated with abnormal endoplasmic reticulum (ER) calcium handling. These abnormalities influence neurotransmission indirectly, without direct ER calcium release into the cytoplasm. However, in cortical cultures and brain slices, there are no significant differences in calcium release between the HD-model neurons and wild-type cells.

JOURNAL OF NEUROSCIENCE (2023)

Article Neurosciences

Hyperglycaemia, pregnancy outcomes and maternal metabolic disease risk during pregnancy and lactation in a lean gestational diabetes mouse model

Angela J. C. Tol, Kaja Hribar, Janine Kruit, Laura Bongiovanni, Marcel A. Vieira-Lara, Mirjam H. Koster, Niels J. Kloosterhuis, Rick Havinga, Martijn Koehorst, Alain de Bruin, Barbara M. Bakker, Maaike H. Oosterveer, Eline M. van der Beek

Summary: Hyperglycaemia in pregnancy (HIP) is a pregnancy complication characterized by mild to moderate hyperglycaemia that negatively impacts the health of mother and child. The study investigated the impact of gestational diabetes mellitus (GDM) and pre-gestational diabetes mellitus (PDM) on maternal health and pregnancy outcomes. The findings indicate that GDM and PDM increase the risk of postpartum non-alcoholic fatty liver disease (NAFLD) development, highlighting the need for earlier monitoring of maternal glycaemia and more rigorous follow-up of maternal health after GDM and PDM pregnancy in humans.

JOURNAL OF PHYSIOLOGY-LONDON (2023)

Article Pharmacology & Pharmacy

The chemotherapeutic drug doxorubicin does not exacerbate p16Ink4a-positive senescent cell accumulation and cardiometabolic disease development in young adult female LDLR-deficient mice

Andrea C. Postmus, Janine K. Kruit, Roos E. Eilers, Rick Havinga, Mirjam H. Koster, Yoshikazu Johmura, Makoto Nakanishi, Bart van de Sluis, Johan W. Jonker

Summary: Cancer survivors who undergo chemotherapy, such as DOX, have an increased risk of developing chronic metabolic diseases. However, in a mouse study, drug-induced cellular senescence did not have a significant impact on long-term metabolic effects.

TOXICOLOGY AND APPLIED PHARMACOLOGY (2023)

Article Clinical Neurology

Pridopidine Does Not Significantly Prolong the QTc Interval at the Clinically Relevant Therapeutic Dose

Borje Darpo, Michal Geva, Georg Ferber, Yigal Paul Goldberg, Andres Cruz-Herranz, Munish Mehra, Richard Kovacs, Michael R. Hayden

Summary: Pridopidine, a selective sigma-1 receptor agonist, shows a favorable cardiac safety profile at the therapeutic dose of 45 mg bid, with no clinically relevant effect on the QT interval.

NEUROLOGY AND THERAPY (2023)

Article Biotechnology & Applied Microbiology

Preclinical Development and Characterization of Novel Adeno-Associated Viral Vectors for the Treatment of Lipoprotein Lipase Deficiency

Neel Mehta, Renald Gilbert, Parminder S. Chahal, Maria J. Moreno, Nasha Nassoury, Nathalie Coulombe, Viktoria Lytvyn, Mario Mercier, Dorothy Fatehi, Wendy Lin, Emily M. Harvey, Lin-Hua Zhang, Nazila Nazemi-Moghaddam, Seyyed Mehdy Elahi, Colin J. D. Ross, Danica B. Stanimirovic, Michael R. Hayden

Summary: This study aimed to develop a more efficacious AAV gene therapy vector for the treatment of LPLD. The researchers identified AAV8 pVR59 as a superior vector compared to AAV1 (Glybera), with significantly better therapeutic effects at lower doses. AAV8 pVR59 treatment led to long-term correction of LPLD and improvement in pathology.

HUMAN GENE THERAPY (2023)

Article Biotechnology & Applied Microbiology

Limitations of Dual-Single Guide RNA CRISPR Strategies for the Treatment of Central Nervous System Genetic Disorders

Fabio Duarte, Gabriel Vachey, Nicholas S. Caron, Melanie Sipion, Maria Rey, Anselme L. Perrier, Michael R. Hayden, Nicole Deglon

Summary: Huntington's disease is a fatal neurodegenerative disorder that can be treated by inactivating the mutated HTT gene. One approach to selectively inactivate the mutant allele is by using the CRISPR/Cas9 system to remove the first exon of the mutated HTT. However, the frequency of deletion events is still uncertain.

HUMAN GENE THERAPY (2023)

Meeting Abstract Oncology

Stereotactic Radiosurgery for Trigeminal Neuralgia Secondary to Tumor: A Single Institutional Retrospective Series

J. C. Hall, T. H. Ung, T. L. McCleary, C. F. Chuang, I. C. Gibbs, S. G. Soltys, M. Hayden, G. Li, E. Pollom, S. D. Chang, A. Meola

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)

Meeting Abstract Clinical Neurology

CEREBROSPINAL FLUID BIOMARKERS FOR ASSESSING HUNTINGTON DISEASE ONSET AND SEVERITY

Nicholas S. Caron, Arsalan S. Haqqani, Akshdeep Sandhu, Amirah E. Aly, Hailey Findlay Black, Jeffrey N. Bone, Jodi L. McBride, Abedelnasser Abulrob, Danica Stanimirovic, Blair R. Leavitt, Michael R. Hayden

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2022)

Meeting Abstract Clinical Neurology

Pridopidine, a selective Sigma-1 receptor (S1R) agonist promotes neuroprotection in ALS models

Michal Geva, Shao-Ming Wang, Hsiang-En Wu, Lior Ankol, Ariel Ionescu, Tal Gradus-Pery, Noga Gershoni-Emek, Y. Paul Goldberg, Tsung-Ping Su, Eran Perlson, Michael R. Hayden

MUSCLE & NERVE (2022)

Article Clinical Neurology

Cerebrospinal fluid biomarkers for assessing Huntington disease onset and severity

Nicholas S. Caron, Arsalan S. Haqqani, Akshdeep Sandhu, Amirah E. Aly, Hailey Findlay Black, Jeffrey N. Bone, Jodi L. McBride, Abedelnasser Abulrob, Danica Stanimirovic, Blair R. Leavitt, Michael R. Hayden

Summary: The study aims to identify molecular biomarkers in the cerebrospinal fluid (CSF) to improve predictions and understanding of Huntington disease. The researchers investigated protein candidates in CSF from individuals with Huntington disease and healthy controls, and found both known and novel biomarkers associated with the disease. They found that combinations of CSF proteins can better stratify individuals based on disease status and severity, and may be useful in predicting disease onset and assessing therapeutic response in clinical trials.

BRAIN COMMUNICATIONS (2022)

暂无数据